SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): February 12, 2004
INVITROGEN CORPORATION
(Exact name of registrant as specified in its charter)
Delaware | 0-25317 | 33-0373077 | ||
(State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
1600 Faraday Avenue, Carlsbad, CA | 92008 | |
(Address of principal executive offices) | (Zip Code) |
Registrants telephone number, including area code: (760) 603-7200
Not Applicable
(Former name or former address, if changed since last report)
Item 5. | OTHER EVENTS |
On February 12, 2004, Invitrogen Corporation (the Company) issued two press releases regarding its offering of $450 million aggregate principal amount of 1.5% Convertible Senior Notes due 2024 plus a 13 day over-allotment option to purchase up to an additional $67.5 million of 1.5% Convertible Senior Notes to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. Attached as Exhibits 99.1 and 99.2 are press releases of the Company regarding the offering of the Convertible Senior Notes. Exhibits 99.1 and 99.2 are incorporated by reference under this Item 5.
Item 7. | FINANCIAL STATEMENTS AND EXHIBITS. |
(c) Exhibits.
Exhibit |
Description | |
99.1 | Invitrogen Corporation press release dated February 12, 2004 regarding the offering of convertible senior notes. | |
99.2 | Invitrogen Corporation press release dated February 12, 2004 regarding the offering of convertible senior notes. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Invitrogen Corporation | ||||||||
Date: February 13, 2004 |
By: | /s/ C. Eric Winzer | ||||||
C. Eric Winzer Chief Financial Officer |
EXHIBIT INDEX
Exhibit |
Description | |
99.1 | Invitrogen Corporation press release dated February 12, 2004 regarding the offering of convertible senior notes. | |
99.2 | Invitrogen Corporation press release dated February 12, 2004 regarding the offering of convertible senior notes. |